Zanidatamab with and without tislelizumab in her2-positive gastroesophageal cancer

by biblioteca on 19 d'octubre de 2026 with No hi ha comentaris

Shitara, K., Elimova, E., Liu, T., Tabernero, J., Lee, K.-W., Schenker, M., Tebbutt, N. C., Ajani, J., Salimin, N., Ku, G., Gwang Kim, J., Ales Diaz, I., Zhang, J., Pietrantonio, F., Bai, L.-Y., Le Sourd, S., Zhao, J., Hierro, C., Kiberu, A., … Shen, L. (2026). Zanidatamab with and without tislelizumab in her2-positive gastroesophageal cancer. New England Journal of Medicine, 394(20), 2002-2014. https://doi.org/10.1056/NEJMoa2517729